Novonesis completes acquisition of MicroBioGen to expand yeast capabilities
AI Summary- Novonesis completed its acquisition of Australian biotechnology company MicroBioGen.
- Novonesis held a 23% ownership stake before completing the transaction.
- All regulatory approvals were obtained, and MicroBioGen’s existing collaborations will continue.